We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Parker Laboratories

Manufactures medical ultrasound and electromedical contact media, including gels, solid gels, lotions and pads read more Featured Products: More products

Download Mobile App




Disposable Dressing Makes Guided IV Insertions Easier

By MedImaging International staff writers
Posted on 11 Sep 2018
Print article
Image: A combination sterile barrier and securement dressing aids UGPIV insertions (Photo courtesy of Parker Laboratories).
Image: A combination sterile barrier and securement dressing aids UGPIV insertions (Photo courtesy of Parker Laboratories).
A combined sterile barrier and securement dressing facilitates ultrasound-guided peripheral intravenous (UGPIV) insertions.

The Parker Laboratories (Fairfield, NJ, USA) UltraDrape dressing is designed to address the challenges that clinicians face with UGPIV insertions, including extended procedure time, increased risk of infection and cross contamination, and securement failure resulting from inadequate gel removal. Ultrasound gel is first applied to a removable film layer, enabling target vessel identification while still keeping the sterile puncture area dry and free from gel. The top layer is then discarded, leaving the area dry for successful fixation.

The major benefit of UltraDrape is that it eliminates the need to clean the ultrasound transmission gel from the patient’s skin prior to IV securement, saving valuable time. In addition, inadequate removal of transmission gel can lead to dressing failure, requiring more frequent changes and higher contamination rates. The sterile, dual-action UltraDrape dressing is provided in a convenient dispenser containing 50 units, lowering the cost of performing aseptic UGPIV insertions by removing the need for additional securement dressings, sterile gels, and probe covers.

“UltraDrape represents an unprecedented advancement enabling UGPIV practitioners to perform procedures efficiently, effectively, and at a significant cost savings when compared with use of sterile gels and covers,” said Neal Buchalter, president of Parker Laboratories. “We are very excited to make UltraDrape available today through our worldwide distribution network.”

“This combination sterile barrier and securement approach makes it easier and faster to achieve success with ultrasound-guided PIV insertions, and it helps me do a better job as a clinician,” said independent consultant in vascular access Nancy Moureau, RN, PhD. “By not applying gel directly to the patient's skin, I can maintain a better no-touch aseptic technique, which lowers the risk of infection and eliminates time-consuming post-procedure clean up.”

UGPIV is recommended when attempts to obtain peripheral intravenous access by standard methods have failed, and in patients with known difficult PIV access without palpable peripheral vessels. The most common area for UGPIV placement is in the antecubital fossa region, with a high-frequency linear array probe as the recommended ultrasound transducer. UGPIV has been shown to improve IV success rates, decrease the number of percutaneous punctures, and decrease the time required to achieve IV access.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
DR Flat Panel Detector
1500L
New
PACS Workstation
CHILI Web Viewer
New
Color Doppler Ultrasound System
KC20

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.